Literature DB >> 21030042

Silver or nitrofurazone impregnation of urinary catheters has a minimal effect on uropathogen adherence.

Devak G Desai1, Kershena S Liao, Manuel E Cevallos, Barbara W Trautner.   

Abstract

PURPOSE: Bacterial adherence to the urinary catheter is an early step in biofilm formation and the pathogenesis of catheter associated urinary tract infection. We studied in vitro the effect of silver or nitrofurazone impregnation of urinary catheters on uropathogen ability to adhere to urinary catheters.
MATERIALS AND METHODS: We studied commercially available nitrofurazone-silicone, silicone only, silver-silicone-hydrogel, silicone-hydrogel, silver-latex-hydrogel and latex-hydrogel catheters. Catheters were incubated in sterile broth for 0, 3, 5, 7 and 10 days, respectively, before inoculation and overnight incubation with Escherichia coli or Enterococcus faecalis.
RESULTS: Adherence of E. coli and E. faecalis to nitrofurazone catheters was significantly decreased compared to that of silicone-only catheters when catheters were fresh. The anti-adherence effect of nitrofurazone on E. coli decreased with time but was still significant at 5 days. For E. faecalis the effect of nitrofurazone was lost by 3 days of pre-incubation. E. coli adherence was not significantly decreased on silver impregnated catheters compared to that on control catheters of the same base material. Silver was associated with a significant decrease in E. faecalis adherence to latex-hydrogel catheters but not to silicone-hydrogel catheters. The adherence of each species to silicone catheters with hydrogel was significantly lower than that to silicone-only control catheters.
CONCLUSIONS: Silver impregnation had little effect on bacterial adherence in our model and nitrofurazone impregnation had a significant effect only for the first 5 days. Our results do not support a role for silver urinary catheters to prevent catheter associated urinary tract infection by decreasing bacterial adherence.
Copyright © 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030042      PMCID: PMC2991122          DOI: 10.1016/j.juro.2010.07.036

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  25 in total

Review 1.  Catheter-associated infections: pathogenesis affects prevention.

Authors:  Barbara W Trautner; Rabih O Darouiche
Journal:  Arch Intern Med       Date:  2004-04-26

2.  Crystalline bacterial biofilm formation on urinary catheters by urease-producing urinary tract pathogens: a simple method of control.

Authors:  Robert J Broomfield; Sheridan D Morgan; Azhar Khan; David J Stickler
Journal:  J Med Microbiol       Date:  2009-06-25       Impact factor: 2.472

3.  Strategies to prevent catheter-associated urinary tract infections in acute care hospitals.

Authors:  Evelyn Lo; Lindsay Nicolle; David Classen; Kathleen M Arias; Kelly Podgorny; Deverick J Anderson; Helen Burstin; David P Calfee; Susan E Coffin; Erik R Dubberke; Victoria Fraser; Dale N Gerding; Frances A Griffin; Peter Gross; Keith S Kaye; Michael Klompas; Jonas Marschall; Leonard A Mermel; David A Pegues; Trish M Perl; Sanjay Saint; Cassandra D Salgado; Robert A Weinstein; Robert Wise; Deborah S Yokoe
Journal:  Infect Control Hosp Epidemiol       Date:  2008-10       Impact factor: 3.254

4.  Activities of a nitrofurazone-containing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection.

Authors:  J R Johnson; P Delavari; M Azar
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

5.  Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis.

Authors:  Barbara W Trautner; Rabih O Darouiche; Richard A Hull; Sheila Hull; John I Thornby
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

6.  Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens.

Authors:  Barbara W Trautner; Richard A Hull; Rabih O Darouiche
Journal:  Urology       Date:  2003-05       Impact factor: 2.649

7.  Construction of the mobilizable plasmid pMV158GFP, a derivative of pMV158 that carries the gene encoding the green fluorescent protein.

Authors:  Concepción Nieto; Manuel Espinosa
Journal:  Plasmid       Date:  2003-05       Impact factor: 3.466

Review 8.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.

Authors:  Betsy Foxman
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

9.  Observations on the development of the crystalline bacterial biofilms that encrust and block Foley catheters.

Authors:  D J Stickler; S D Morgan
Journal:  J Hosp Infect       Date:  2008-06-11       Impact factor: 3.926

10.  Catheter-associated urinary tract infection and the Medicare rule changes.

Authors:  Sanjay Saint; Jennifer A Meddings; David Calfee; Christine P Kowalski; Sarah L Krein
Journal:  Ann Intern Med       Date:  2009-06-16       Impact factor: 25.391

View more
  25 in total

Review 1.  The emerging threat of multidrug-resistant Gram-negative bacteria in urology.

Authors:  Hosam M Zowawi; Patrick N A Harris; Matthew J Roberts; Paul A Tambyah; Mark A Schembri; M Diletta Pezzani; Deborah A Williamson; David L Paterson
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

Review 2.  Neurogenic detrusor overactivity in patients with spinal cord injury: evaluation and management.

Authors:  Arun Sahai; Eduardo Cortes; Jai Seth; Muhammad Shamim Khan; Jalesh Panicker; Cornelius Kelleher; Thomas M Kessler; Clare J Fowler; Prokar Dasgupta
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

3.  In vitro evaluation of the impact of silver coating on Escherichia coli adherence to urinary catheters.

Authors:  Adam T Ogilvie; Brigitte A Brisson; Ameet Singh; J Scott Weese
Journal:  Can Vet J       Date:  2015-05       Impact factor: 1.008

Review 4.  The Use of Copper as an Antimicrobial Agent in Health Care, Including Obstetrics and Gynecology.

Authors:  Linda P Arendsen; Ranee Thakar; Abdul H Sultan
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

5.  Surfaces Presenting α-Phenyl Mannoside Derivatives Enable Formation of Stable, High Coverage, Non-pathogenic Escherichia coli Biofilms against Pathogen Colonization.

Authors:  Zhiling Zhu; Jun Wang; Analette I Lopez; Fei Yu; Yongkai Huang; Amit Kumar; Siheng Li; Lijuan Zhang; Chengzhi Cai
Journal:  Biomater Sci       Date:  2015-06-01       Impact factor: 6.843

6.  Biofunctionalization of silicone polymers using poly(amidoamine) dendrimers and a mannose derivative for prolonged interference against pathogen colonization.

Authors:  Analette I Lopez; Amit Kumar; Megan R Planas; Yan Li; Thuy V Nguyen; Chengzhi Cai
Journal:  Biomaterials       Date:  2011-03-24       Impact factor: 12.479

7.  Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model.

Authors:  Susan M Lehman; Rodney M Donlan
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

8.  Bacteria responsive antibacterial surfaces for indwelling device infections.

Authors:  Christian Traba; Jun F Liang
Journal:  J Control Release       Date:  2014-12-04       Impact factor: 9.776

9.  Silver oxynitrate, an unexplored silver compound with antimicrobial and antibiofilm activity.

Authors:  Joe A Lemire; Lindsay Kalan; Alexandru Bradu; Raymond J Turner
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

10.  Antibiotic-decorated titanium with enhanced antibacterial activity through adhesive polydopamine for dental/bone implant.

Authors:  Shu He; Ping Zhou; Linxin Wang; Xiaoling Xiong; Yifei Zhang; Yi Deng; Shicheng Wei
Journal:  J R Soc Interface       Date:  2014-03-19       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.